Quantinuum (NASDAQ:QNT) Stock Rating Raised to "Hold" at Wall Street Zen

Key Points

• Wall Street Zen upgraded Quantinuum from “Sell” to “Hold.” Overall analyst sentiment remains “Moderate Buy,” with an average price target of $85.62.
• Quantinuum reported a quarterly loss of $0.29 per share, beating the $0.99 loss analysts expected, on revenue of $9.05 million. The company also raised its full-year 2026 revenue outlook.
• Some analysts cut price targets despite retaining positive ratings: JPMorgan lowered its target to $80 from $97, and Cantor Fitzgerald reduced its target to $55 from $90.

Quantinuum (NASDAQ:QNT - Get Free Report) was upgraded by analysts at Wall Street Zen from a "sell" rating to a "hold" rating in a research note issued to investors on Saturday, Wall Street Zen reports.

QNT has been the topic of a number of other reports. JPMorgan Chase & Co. lowered their target price on Quantinuum from $97.00 to $80.00 and set an "overweight" rating on the stock in a research report on Friday. Cantor Fitzgerald lowered their price target on Quantinuum from $90.00 to $55.00 and set an "overweight" rating for the company in a research report on Friday. Morgan Stanley raised Quantinuum from an "equal weight" rating to an "overweight" rating and cut their price target for the stock from $78.00 to $62.00 in a research report on Thursday, October 15th. Yorkville Ives began coverage on shares of Quantinuum in a report on Monday, October 5th. They set an "outperform" rating and a $60.00 target price on the stock. Finally, Weiss Ratings assumed coverage on Quantinuum in a research note on Monday, August 31st. They set a "sell (d)" rating on the stock. Thirteen analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $85.62.

Quantinuum Stock Performance

Shares of NASDAQ QNT opened at $37.57 on Friday. Quantinuum has a 12-month low of $28.31 and a 12-month high of $86.79. The company has a fifty day moving average of $43.41.

Quantinuum (NASDAQ:QNT - Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported ($0.29) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.99) by $0.70. The firm had revenue of $9.05 million for the quarter. As a group, analysts anticipate that Quantinuum will post -4.76 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Wellington Management Group LLP acquired a new position in Quantinuum in the 2nd quarter valued at about $92,418,000. HBK Investments L P bought a new position in Quantinuum in the second quarter valued at about $14,669,000. BlueCrest Capital Management Ltd purchased a new stake in shares of Quantinuum during the 2nd quarter worth approximately $14,304,000. Readystate Asset Management LP purchased a new stake in Quantinuum in the second quarter worth $4,111,000. Finally, Light Street Capital Management LLC bought a new stake in Quantinuum during the 2nd quarter valued at approximately $2,881,000.

Key Stories Impacting Quantinuum

Here are the key news stories impacting Quantinuum this week:

• Positive Sentiment: Quantinuum beat third-quarter expectations, reporting a loss of $0.29 per share versus the $0.99 loss analysts expected. Revenue rose 233% year over year to $9.05 million, and the company raised its full-year 2026 revenue outlook. The report also noted that gross margin turned positive, although expenses are increasing. Quantinuum Q3 results and outlook
• Positive Sentiment: Commercial traction strengthened: Quantinuum said it secured its largest cloud agreement to date, expanded access through a hyperscaler and an Oracle beta launch, and saw platform adoption rise nearly 20% quarter over quarter. These developments could help build future revenue. Quantinuum Q3 results and outlook
• Positive Sentiment: The company outlined its Nexus developer-platform roadmap, connecting application development with future hardware, including its planned Apollo fault-tolerant quantum computer. The roadmap and reported technical milestones could strengthen Quantinuum’s longer-term competitive position. Nexus roadmap announcement
• Negative Sentiment: Some analysts lowered their forecasts and price targets after the results. Cantor Fitzgerald cut its target from $90 to $55 and Needham lowered its target from $100 to $60, though both retained positive ratings—Overweight and Buy, respectively. The cuts may temper enthusiasm despite the earnings beat. Analysts cut forecasts after Q3 results

Quantinuum Company Profile

Quantinuum is a quantum computing company formed in 2021 through the combination of Honeywell Quantum Solutions and Cambridge Quantum. The company develops full-stack quantum computing technologies designed to support research and commercial applications across industries, including chemistry, materials science, cybersecurity, finance and artificial intelligence.

Its offerings include trapped-ion quantum computers, quantum software and development tools. Quantinuum's software portfolio includes the TKET quantum compiler, InQuanto quantum chemistry platform, Quantum Origin quantum-enhanced cybersecurity solutions and the Nexus platform for developing and managing quantum applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.